The DOI matches its Crossref record.
Reversal of Left Ventricular Hypertrophy in Hypertensive Patients
Abstract
This is a metaanalysis of all available studies as of December 1990 that have evaluated the effect of antihypertensive pharmacologic therapy on left ventricular structure examined by echocardiography. We applied preset inclusion criteria to the analysis. A total of 109 studies comprising 2357 patients (28% previously untreated) with an average age of 49 years (range 30 to 71) were included. Overall left ventricular mass (LVM) was reduced by 11.9% [95% confidence interval (CI) 10.1 to 13.7] in parallel with a reduction of mean arterial pressure of 14.9% (CI 14 to 15.8). To differentiate between first-line therapies and to adjust for differences between studies, we performed ANCOVA. Angiotensin converting enzyme (ACE) inhibitors reduced LVM by 15% (CI 9.9 to 20.1), beta-blockers by 8% (CI 4.8 to 11.2), calcium antagonists by 8.5% (CI 5.1 to 11.8), and diuretics by 11.3% (CI 5.6 to 17). When we calculated LVM using the same formula for all studies the absolute reductions in grams were 44.7 g with ACE inhibitors, 22.8 g with beta-blockers, 26.9 g with calcium antagonists, and 21.4 g with diuretics. Except for diuretics, all therapies mainly affected wall thickness, while diuretics predominantly reduced ventricular diameter. In conclusion, this metaanalysis shows that ACE inhibitors, beta-blockers, and calcium antagonists all reduce LVM by reversing wall hypertrophy, and that the effect is most pronounced with ACE inhibitors. Conversely, diuretics reduce LVM mainly through a reduction of left ventricular volume. Based on these data, we hypothesize that ACE inhibitors are more effective than other first-line therapies in reducing LVM. However, this theory and its possible prognostic implications need to be evaluated in controlled prospective trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Self-citationHansson, L., Lindholm, L. H., Niskanen, L., Lanke, J., Hedner, T., Niklason, A., Luomanmäki, K., Dahlöf, B., de Faire, U., Mörlin, C., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)05012-0 · Cited by 2,014
Self-citationLeft Ventricular Hypertrophy: Pathogenesis, Detection, and Prognosis
Lorell, B. H., & Carabello, B. A. (2000) · Circulation · doi:10.1161/01.cir.102.4.470 · Cited by 1,232
Blood Pressure as a Cardiovascular Risk Factor: Prevention and Treatment
Kannel, W. B. (1996) · JAMA · doi:10.1001/jama.1996.03530440051036 · Cited by 1,230
Hormones and Hemodynamics in Heart Failure
Schrier, R. W., & Abraham, W. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410806 · Cited by 1,199
Wing, L. M. H., Reid, C. M., Ryan, P., Beilin, L. J., Brown, M. A., Jennings, G. L. R., Johnston, C. I., McNeil, J. J., Macdonald, G. J., Marley, J. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021716 · Cited by 1,130
Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients
Perticone, F., Ceravolo, R., Pujia, A., Ventura, G., Iacopino, S., Scozzafava, A., Ferraro, A., Chello, M., Mastroroberto, P., Verdecchia, P., et al. (2001) · Circulation · doi:10.1161/01.cir.104.2.191 · Cited by 1,059
The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
Psaty, B. M. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530080036038 · Cited by 1,003
Hansson, L., Hedner, T., Lund-Johansen, P., Kjeldsen, S. E., Lindholm, L. H., Syvertsen, J. O., Lanke, J., de Faire, U., Dahlöf, B., & Karlberg, B. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02526-5 · Cited by 905
Self-citationLeft ventricular mass index increase in early renal disease: Impact of decline in hemoglobin
Levin, A., Thompson, C. R., Ethier, J., Carlisle, E. J. F., Tobe, S., Mendelssohn, D., Burgess, E., Jindal, K., Barrett, B., Singer, J., et al. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70118-6 · Cited by 841
Cheitlin, M. D., Alpert, J. S., Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, F. Z., Davidson, T. W., Davis, J. L., Douglas, P. S., Gillam, L. D., et al. (1997) · Circulation · doi:10.1161/01.cir.95.6.1686 · Cited by 831
A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension
Klingbeil, A. U., Schneider, M., Martus, P., Messerli, F. H., & Schmieder, R. E. (2003) · The American Journal of Medicine · doi:10.1016/s0002-9343(03)00158-x · Cited by 761
Levin, A., Singer, J., Thompson, C. R., Ross, H., & Lewis, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90357-1 · Cited by 709
Cytoplasmic Signaling Pathways That Regulate Cardiac Hypertrophy
Molkentin, J. D., & Dorn II, G. W. (2001) · Annual Review of Physiology · doi:10.1146/annurev.physiol.63.1.391 · Cited by 689
Prognostic Significance of Serial Changes in Left Ventricular Mass in Essential Hypertension
Verdecchia, P., Schillaci, G., Borgioni, C., Ciucci, A., Gattobigio, R., Zampi, I., Reboldi, G., & Porcellati, C. (1998) · Circulation · doi:10.1161/01.cir.97.1.48 · Cited by 655
Lisinopril-Mediated Regression of Myocardial Fibrosis in Patients With Hypertensive Heart Disease
Brilla, C. G., Funck, R. C., & Rupp, H. (2000) · Circulation · doi:10.1161/01.cir.102.12.1388 · Cited by 649
Gibbons, R. J., Chatterjee, K., Daley, J., Douglas, J. S., Fihn, S. D., Gardin, J. M., Grunwald, M. A., Levy, D., Lytle, B. W., O’Rourke, R. A., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00150-3 · Cited by 633
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G., Brown, A. S., Ferdinand, K. C., Forciea, M. A., Frishman, W. H., Jaigobin, C., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31821daaf6 · Cited by 614
Schmieder, R. E. (1996) · JAMA · doi:10.1001/jama.1996.03530430051039 · Cited by 604
Collins, R., & MacMahon, S. (1994) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072892 · Cited by 587
Arterial hypertension in adults. Clinical guidelines 2020
Kobalava, Z. D., Konradi, A. O., Nedogoda, S. V., Shlyakhto, E. V., Arutyunov, G. P., Baranova, E. I., Barbarash, O. L., Boitsov, S. A., Vavilova, T. V., Villevalde, S. V., et al. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-3-3786 · Cited by 541
ACCF/AHA 2011 Expert Consensus Document on Hypertension in the Elderly
Aronow, W. S., Fleg, J. L., Pepine, C. J., Artinian, N. T., Bakris, G., Brown, A. S., Ferdinand, K. C., Ann Forciea, M., Frishman, W. H., Jaigobin, C., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.01.008 · Cited by 514
Brandt, M. C., Mahfoud, F., Reda, S., Schirmer, S. H., Erdmann, E., Böhm, M., & Hoppe, U. C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.11.034 · Cited by 501
Devereux, R. B., Dahlöf, B., Gerdts, E., Boman, K., Nieminen, M. S., Papademetriou, V., Rokkedal, J., Harris, K. E., Edelman, J. M., & Wachtell, K. (2004) · Circulation · doi:10.1161/01.cir.0000141573.44737.5a · Cited by 470
Kjeldsen, S. E., Dahlöf, B., Devereux, R. B., Julius, S., Aurup, P., Edelman, J., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., et al. (2002) · JAMA · doi:10.1001/jama.288.12.1491 · Cited by 443
Self-citationMicroalbuminuria and endothelial dysfunction in essential hypertension
PEDRINELLI, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91047-2 · Cited by 383
Kokkinos, P. F., Narayan, P., Colleran, J. A., Pittaras, A., Notargiacomo, A., Reda, D., & Papademetriou, V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332204 · Cited by 354
Moser, M., & Hebert, P. R. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00606-0 · Cited by 345
Effect of different antihypertensive drug classes on central aortic pressure
Morgan, T. (2004) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2003.09.012 · Cited by 330
Muiesan, M. L., Salvetti, M., Monteduro, C., Bonzi, B., Paini, A., Viola, S., Poisa, P., Rizzoni, D., Castellano, M., & Agabiti-Rosei, E. (2004) · Hypertension · doi:10.1161/01.hyp.0000121223.44837.de · Cited by 330
Solomon, S. D., Janardhanan, R., Verma, A., Bourgoun, M., Daley, W. L., Purkayastha, D., Lacourcière, Y., Hippler, S. E., Fields, H., Naqvi, T. Z., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60980-5 · Cited by 329
Liebson, P. R., Grandits, G. A., Dianzumba, S., Prineas, R. J., Grimm, R. H., Neaton, J. D., & Stamler, J. (1995) · Circulation · doi:10.1161/01.cir.91.3.698 · Cited by 326
Fagard, R. H., Celis, H., Thijs, L., & Wouters, S. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.136655 · Cited by 314
Primary hyperparathyroidism and heart disease ? a review
ANDERSSON, P., RYDBERG, E., & WILLENHEIMER, R. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.07.010 · Cited by 303
Gradman, A. H., & Alfayoumi, F. (2006) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2006.02.001 · Cited by 301
Solomon, S. D., Appelbaum, E., Manning, W. J., Verma, A., Berglund, T., Lukashevich, V., Cherif Papst, C., Smith, B. A., & Dahlöf, B. (2009) · Circulation · doi:10.1161/circulationaha.108.826214 · Cited by 301
Assessment of Left Ventricular Mass by Cardiovascular Magnetic Resonance
Myerson, S. G., Bellenger, N. G., & Pennell, D. J. (2002) · Hypertension · doi:10.1161/hy0302.104674 · Cited by 298
Gottdiener, J. S., Reda, D. J., Massie, B. M., Materson, B. J., Williams, D. W., & Anderson, R. J. (1997) · Circulation · doi:10.1161/01.cir.95.8.2007 · Cited by 284
Autonomic imbalance, hypertension, and cardiovascular risk
BROOK, R. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00228-4 · Cited by 257
Niskanen, L., Hedner, T., Hansson, L., Lanke, J., Niklason, A., & for the CAPPP study group (2001) · Diabetes Care · doi:10.2337/diacare.24.12.2091 · Cited by 219
Self-citationCardiovascular drug therapy in the elderly: benefits and challenges
Fleg, J. L., Aronow, W. S., & Frishman, W. H. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.162 · Cited by 186
Karason, K., Wallentin, I., Larsson, B., & Sjostrom, L. (1997) · BMJ · doi:10.1136/bmj.315.7113.912 · Cited by 168
Harrap, S. B., Dominiczak, A. F., Fraser, R., Lever, A. F., Morton, J. J., Foy, C. J., & Watt, G. C. M. (1996) · Circulation · doi:10.1161/01.cir.93.6.1148 · Cited by 109
Effects of chronic hormone replacement on the renin–angiotensin system in cynomolgus monkeys
Brosnihan, K. B., Weddle, D., Anthony, M. S., Heise, C., Li, P., & Ferrario, C. M. (1997) · Journal of Hypertension · doi:10.1097/00004872-199715070-00003 · Cited by 70
MIYAI, N., ARITA, M., MIYASHITA, K., MORIOKA, I., SHIRAISHI, T., NISHIO, I., & TAKEDA, S. (2002) · Hypertension Research · doi:10.1291/hypres.25.507 · Cited by 33
Metadata
- Authors
- Dahlöf, B., Pennert, K., & Hansson, L.
- Venue
- American Journal of Hypertension
- Publisher
- Oxford University Press (OUP)
- Published
- 1992-01
- Volume
- 5
- Issue
- 2
- Pages
- 95-110
- ISSN
- 0895-7061 (ISSN-L)
- 1941-7225
- OpenAlex
- W1769893219
- Cited by
- 925
- References
- 0
- FWCI
- 40.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.